Zurich Cantonal Bank’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-211
| Closed | -$37.4K | – | 2865 |
|
|
2023
Q1 | $37.4K | Hold |
211
| – | – | ﹤0.01% | 2658 |
|
|
2022
Q4 | $81.7K | Buy |
211
+47
| +29% | +$18.2K | ﹤0.01% | 2391 |
|
|
2022
Q3 | $55K | Hold |
164
| – | – | ﹤0.01% | 2563 |
|
|
2022
Q2 | $54K | Hold |
164
| – | – | ﹤0.01% | 2560 |
|
|
2022
Q1 | $72K | Sell |
164
-120
| -42% | -$52.7K | ﹤0.01% | 2420 |
|
|
2021
Q4 | $124K | Sell |
284
-12
| -4% | -$5.24K | ﹤0.01% | 2395 |
|
|
2021
Q3 | $164K | Buy |
296
+4
| +1% | +$2.22K | ﹤0.01% | 2047 |
|
|
2021
Q2 | $150K | Buy |
292
+128
| +78% | +$65.8K | ﹤0.01% | 2009 |
|
|
2021
Q1 | $128K | Hold |
164
| – | – | ﹤0.01% | 2025 |
|
|
2020
Q4 | $89K | Hold |
164
| – | – | ﹤0.01% | 2264 |
|
|
2020
Q3 | $75K | Hold |
164
| – | – | ﹤0.01% | 2110 |
|
|
2020
Q2 | $101K | Buy |
164
+96
| +141% | +$59.1K | ﹤0.01% | 1937 |
|
|
2020
Q1 | $32K | Hold |
68
| – | – | ﹤0.01% | 2156 |
|
|
2019
Q4 | $40K | Hold |
68
| – | – | ﹤0.01% | 2260 |
|
|
2019
Q3 | $45K | Hold |
68
| – | – | ﹤0.01% | 2114 |
|
|
2019
Q2 | $53K | Hold |
68
| – | – | ﹤0.01% | 2028 |
|
|
2019
Q1 | $48K | Sell |
68
-32
| -32% | -$22.6K | ﹤0.01% | 2037 |
|
|
2018
Q4 | $47K | Buy |
100
+27
| +37% | +$12.7K | ﹤0.01% | 2074 |
|
|
2018
Q3 | $63K | Hold |
73
| – | – | ﹤0.01% | 2010 |
|
|
2018
Q2 | $50K | Sell |
73
-47
| -39% | -$32.2K | ﹤0.01% | 2133 |
|
|
2018
Q1 | $53K | Hold |
120
| – | – | ﹤0.01% | 2035 |
|
|
2017
Q4 | $53K | Buy |
+120
| New | +$53K | ﹤0.01% | 2032 |
|